Search Results 931-940 of 19936 for anemia

  1. Cyclosporine (intravenous route) - Side effects & uses - Mayo Clinic

    Anemia or; Bleeding problems or; Brain ... This medicine may cause thrombotic microangiopathy (damage in the smallest blood vessels) and hemolytic anemia.

  2. Fatty liver disease (MASLD) - Diagnosis and treatment - Mayo Clinic

    This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

  3. Colon cancer rates continue to be on the rise in younger populations. The colon cancer screening guidelines were lowered from ag

    Ongoing stomach discomfort and unexplained weight loss can be symptoms. Warning symptoms of colon cancer. • Rectal bleeding. • Anemia. • Change in bowel habits.

  4. Transfusion Medicine Fellowship (Minnesota) - Curriculum

    ... anemia. UT performs, on average, three to four red cell exchanges a week for sickle cell anemia, including exchanges for stroke prophylaxis. The medical ...

  5. A Second Trial of the Abbreviated Protocol Two-Stage Exchange - Mayo Clinic

    Patients who are immunodeficient (e.g., splenectomy, sickle cell anemia, Stage 3 HIV infection, primary immunodeficiency disease), except patients who are ...

  6. Publications - Deanne T. Kashiwagi, M.D. - Mayo Clinic

    Acute kidney injury in a patient with hemolytic anemia and thrombocytopenia. JAAPA. 2016 Nov; 29 (11):1-4. View PubMed; Burgess MJ, Enzler MJ, Kashiwagi DT ...

  7. A Study To Evaluate The Safety And Effectiveness Of Bimagrumab On Improvement In Total Lean Body Mass And Physical Performance Following Surgical Treatment Of Hip Fracture. - Mayo Clinic

    ... anemia (hemoglobin less than 8.0 g/dL); Active systemic infection requiring treatment with IV anti-infectives within 4 weeks of randomization; Chronic active ...

  8. Hematology - Clinical trials

    A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS). Jacksonville, Fla. The purpose of phase 2a is to ...

  9. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    Ongoing medical condition (e.g., wasting or cachexia, severe anemia) that according to the Investigator would interfere with the conduct or assessments of the ...

  10. A Study to Evaluate Obinutuzumab to Treat Immunosuppression-dependent or Immunosuppression/Treatment-resistant Focal Segmental Glomerulosclerosis - Mayo Clinic

    Anemia with Hgb < 8.0 g/dL. Thrombocytopenia with platelet count < 100'000. Any other disease, metabolic dysfunction, physical examination finding, or ...